Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 12 min ago
PreprintAll rights reservedbioRxiv

Limited cross strain CMV protection by a bivalent (gB/pp65) vaccine is based on an impaired gB antibody response and evasion of pp65 cell mediated immunity

  • K. Yeon Choi
  • Yushu Qin
  • Nadia El-Hamdi
  • Alistair McGregor
Read full textPDFDOICite

Related

  1. Interaction with complement factor C1q can contribute to and improve monoclonal antibody-mediated protection against lethal HSV-1 challenge
    Lesle M. Jimenez, Matthew D. Slein, David A. Leib +1
    bioRxivPreprintCC BY-NCFull textImmunologybioRxivPMC
  2. Tc17-driven antibody-independent mucosal immunity is critical for protection against extracellular bacterial pneumonia
    Y. Liu, J. Zhang, Z. Chen +4
    bioRxivPreprintAll rights reservedFull textImmunologybioRxiv
  3. A human-derived two-antibody cocktail confers prophylactic and therapeutic protection against authentic Mpox virus.
    B. Kalveram, A. Adam, J. Kapetshi +4
    bioRxivPreprintAll rights reservedFull textMicrobiologybioRxiv
  4. A tri-modular feline infectious peritonitis virus nanoparticle vaccine confers complete protection in female cats without detectable antibody-dependent enhancement
    Feiyu Zhao, Dan Yang, Haixin Liu +18
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full textZoology & animal behaviourCrossref
  5. Dizocilpine-derived K2060 exhibits enhanced blockage at NMDA receptors with impaired Mg2+ block and provides strong protection against audiogenic seizures
    M. Kolcheva, J. Netolicky, A. Misiachna +14
    bioRxivPreprintCC BYFull textNeurosciencebioRxiv

Cite

BibTeXRIS
BibTeX
@misc{choi2026limited,
  title = {{Limited cross strain CMV protection by a bivalent (gB/pp65) vaccine is based on an impaired gB antibody response and evasion of pp65 cell mediated immunity}},
  author = {K. Yeon Choi and Yushu Qin and Nadia El-Hamdi and Alistair McGregor},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.28.762556},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.28.762556v1},
}
RIS
TY  - UNPB
TI  - Limited cross strain CMV protection by a bivalent (gB/pp65) vaccine is based on an impaired gB antibody response and evasion of pp65 cell mediated immunity
AU  - K. Yeon Choi
AU  - Yushu Qin
AU  - Nadia El-Hamdi
AU  - Alistair McGregor
PY  - 2026
DA  - 2026/10/28
PB  - bioRxiv
DO  - 10.64898/2026.10.28.762556
UR  - https://www.biorxiv.org/content/10.64898/2026.10.28.762556v1
SN  - 2692-8205
ER  -